Thermo Fisher Scientific Overview
Valuation check: TMO's P/E ratio is 31.9, above the Healthcare sector average of 26.36.
Get informed when a big investor buys or sells
+ Follow31.90
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, TMO shows a P/E ratio of 31.9. That is above the Healthcare sector average of 26.36. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 26.36. Thermo Fisher Scientific is at 31.9, which is higher that average. That is roughly 21.0% above the sector mean. Use the comparison chart on this page to see how TMO stacks up against individual peers as well.
Investors watch TMO's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Thermo Fisher Scientific's latest reading is 31.9. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Thermo Fisher Scientific's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 31.9) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 26.36, while TMO is at 31.9. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
